As seen here: Antidepressant Use in Children, Adolescents, and Adults
The Food and Drug Administration (FDA) asks manufacturers of all antidepressant drugs to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality (suicidal thinking and behavior) in children and adolescents being treated with these agents, and additional information about the results of pediatric studies.Complete with an extensive collection of FDA papers on the controversial drugs
No comments:
Post a Comment